Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Efficacy and safety of agomelatine given orally compared to placebo, in addition to a mood stabiliser in bipolar I patients with a current major depressive episode. An eight week randomised, double-blind, controlled, parallel group study followed by a double-blind extension treatment period up to one year https://kusajili.fr:443/Trial/kgNcZiEYiU2pAV-ypxCaWw%24efficacy-and-safety-of-agomelatine-given-orally-compared-to-placebo-in-addition-to-a-mood-stabiliser-in-bipolar-i-patients-with
I have read and accept the terms of use of the site and the Privacy Policy
Send your message